<--- Back to Details
First PageDocument Content
Health / Pharmaceutical industry / Pharmacy / Generic drug / Public domain / Prescription costs / Generic Pharmaceutical Price Decay / Pharmaceuticals policy / Pharmaceutical sciences / Pharmacology
Date: 2015-03-03 19:31:35
Health
Pharmaceutical industry
Pharmacy
Generic drug
Public domain
Prescription costs
Generic Pharmaceutical Price Decay
Pharmaceuticals policy
Pharmaceutical sciences
Pharmacology

Toward competitive generic drug prices in Canada

Add to Reading List

Source URL: medicalxpress.com

Download Document from Source Website

File Size: 20,06 KB

Share Document on Facebook

Similar Documents

Business / Pharmaceutical industry / Competition / Pharmaceutical sciences / Pharmaceutical Benefits Scheme / Generic drug / Price / Generic Pharmaceutical Price Decay / Pharmaceuticals policy / Pricing / Marketing

PROPOSED EX-MANUFACTURER PRICING FOR THE PBS Proposed amendments to the National Health Act[removed]the Act) currently being considered by Parliament will introduce ex-manufacturer pricing for the Pharmaceutical Benefits S

DocID: YQ0s - View Document

Health / Pharmaceutical industry / Pharmacy / Generic drug / Public domain / Prescription costs / Generic Pharmaceutical Price Decay / Pharmaceuticals policy / Pharmaceutical sciences / Pharmacology

Toward competitive generic drug prices in Canada

DocID: RRPA - View Document

Generic drug / Public domain / Health policy / Health / Abbreviated New Drug Application / IMS Health / Healthcare reform / Pharmacology / Generic Pharmaceutical Price Decay / Pharmaceuticals policy / Pharmaceutical industry / Pharmaceutical sciences

Analytical Snapshot: International Generic Price Comparison, Early 2011 August[removed]NPDUIS

DocID: M6A6 - View Document

Pharmacology / Intellectual property law / Pharmacy / Generic drug / Patent / Innovation / Generic Pharmaceutical Price Decay / Health Impact Fund / Pharmaceutical sciences / Pharmaceuticals policy / Pharmaceutical industry

Intellectual Property, Competition and Access in Europe: The flawed incentives of the current model 18 November 2010 Sophie Bloemen Health Action International (HAI) Europe

DocID: xNnH - View Document

Health / Pharmaceutical industry / Generic drug / Irish Pharmaceutical Healthcare Association / Prescription medication / Pharmacy / Medical prescription / Pharmaceutical drug / Generic Pharmaceutical Price Decay / Pharmaceutical sciences / Pharmacology / Pharmaceuticals policy

Microsoft Word - DAF-COMP-WD_2009_108 - IRELAND.doc

DocID: cctA - View Document